XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net (loss)/income $ (3,756,262) $ 36,180,584
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and other amortization 393,667 397,136
(Gain)/loss on change in fair value of warrant liability (294,548) 2,909,808
Stock-based compensation 957,320 963,372
Loss on inventory, net 548,551 0
Deferred income taxes, net (408,233) 7,666,891
Loss on extinguishment of Term Loan 0 4,981,461
Non-cash interest expense 0 887,132
Changes in assets and liabilities:    
Accounts receivable (482,561) (36,230,712)
Inventory (9,956,076) 1,507,995
Prepaid expenses and other assets (139,984) 1,494,821
Accounts payable, accrued expenses and other liabilities 8,223,757 474,736
Deferred revenue 306,443 4,339,626
Net cash (used in)/provided by operating activities (4,607,926) 25,572,850
Cash flows from investing activities:    
Capital expenditures (24,424) (15,501)
Net cash used in investing activities (24,424) (15,501)
Cash flows from financing activities:    
Payment of employee tax obligations for common stock tendered (173,918) (184,009)
Repurchase of common stock (20,264,547) (21,783,289)
Repayment of Term Loan 0 (85,913,459)
Net cash used in financing activities (20,438,465) (107,880,757)
Net decrease in cash, cash equivalents and restricted cash (25,070,815) (82,323,408)
Cash, cash equivalents and restricted cash at the beginning of period 117,890,240 160,986,934
Cash and cash equivalents at end of period $ 92,819,425 $ 78,663,526